Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-13

Clinical Trial Update: Magnesium Treating Subarachnoid Hemorrhage Vasospasm [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating magnesium for treating cerebral vasospasm after aneurysmal subarachnoid hemorrhage, spanning Phase 2 and Phase 3, with unknown cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium (magnesium)

Snippet

Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt | Conditions: Subarachnoid Hemorrhage, Aneurysmal, Cerebral Vasospasm | Phase 2, Phase 3 | Status: UNKNOWN